Tech Company Financing Transactions
ReproCELL Funding Round
ReproCELL secured a investment round on 6/9/2026. Investors included Maryland Stem Cell Research Fund.
Transaction Overview
Company Name
Announced On
6/9/2026
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Investors
Maryland Stem Cell Research Fund (Ruchika Nijhara)
Proceeds Purpose
The funding will support the development of clinical grade, hypoimmune induced pluripotent stem cell (iPSC) seed stocks for clinical applications.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
9000 Virginia Manor Road 207
Beltsville, MD 20705
USA
Beltsville, MD 20705
USA
Phone
Website
Email Address
Overview
Our portfolio includes an extensive product catalog to support stem cell research and 3D bioengineered tissues, a commercial biorepository of ethically-sourced human tissues, extensive clinical networks across the USA and Europe that enable our contract research services in human ex vivo living tissues, and our capability to supply induced pluripotent stem cells (iPSCs) for both research and clinical applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chikafumi Yokoyama
Chief Operating Officer
Daisuke Usui
Browse more venture capital transactions:
Prev: 6/9/2026: Cellares venture capital transaction
Next: 6/9/2026: Golden Analytics venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs